• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550300-38
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Death (1802); No Consequences Or Impact To Patient (2199)
Event Date 11/02/2019
Event Type  Death  
Manufacturer Narrative
(b)(4).Exemption number e2019001.The stent remains in patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Study patient (b)(6).It was reported that on (b)(6) 2019, a 3.0 x 38 mm xience sierra stent was implanted in the mid right coronary artery (rca).On (b)(6) 2019, the patient died.No additional information was provided.
 
Manufacturer Narrative
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of death is listed in the xience sierra, everolimus eluting coronary stent systems instructions for use, as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
Subsequent to the follow-up # 1 medwatch report, the following information was received: per the study physician, the patient death is not related to the study device or study procedure.Approximately 2 months post procedure, the patient was re-hospitalized with acute respiratory failure, recurrent pleural effusions and hypotension.A chest x-ray and echocardiogram were performed.Right lung thoracentesis was performed and 1.5 liters of fluid were removed.The patient was unable to maintain blood pressure without fluid bolus and her mental status declined.The patient's family opted for comfort care, and on (b)(6)2019 , the patient died.Although the patient death is not related to the implanted xience sierra stent or procedure, this event has been reported; therefore, it will remain reportable.No additional information was provided.
 
Manufacturer Narrative
An investigation was not conducted because there were no specific reported device malfunctions or patient effects associated with the device.There is no indication of a product quality issue with respect to design, manufacture or labeling.B1, b2, h1: no adverse event or device malfunction occurred as related to the implanted stent h6: patient code 1802 removed device code 2993 removed results code 213 removed conclusions code 22 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9454807
MDR Text Key170416095
Report Number2024168-2019-14414
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648227301
UDI-Public08717648227301
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 04/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/23/2020
Device Model Number1550300-38
Device Catalogue Number1550300-38
Device Lot Number9051641
Was Device Available for Evaluation? No
Date Manufacturer Received04/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age82 YR
Patient Weight58
-
-